ATE526047T1 - Verbesserung der funktion von organen - Google Patents
Verbesserung der funktion von organenInfo
- Publication number
- ATE526047T1 ATE526047T1 AT06022636T AT06022636T ATE526047T1 AT E526047 T1 ATE526047 T1 AT E526047T1 AT 06022636 T AT06022636 T AT 06022636T AT 06022636 T AT06022636 T AT 06022636T AT E526047 T1 ATE526047 T1 AT E526047T1
- Authority
- AT
- Austria
- Prior art keywords
- matrix
- seeded
- vascular system
- vivo
- develop
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0685—Bladder epithelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/26—Materials or treatment for tissue regeneration for kidney reconstruction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/28—Vascular endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/04—Screening or testing on artificial tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Compounds Of Unknown Constitution (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33150001P | 2001-11-16 | 2001-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE526047T1 true ATE526047T1 (de) | 2011-10-15 |
Family
ID=23294225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06022636T ATE526047T1 (de) | 2001-11-16 | 2002-11-12 | Verbesserung der funktion von organen |
Country Status (12)
Country | Link |
---|---|
US (3) | US20030124099A1 (de) |
EP (3) | EP2292278B1 (de) |
JP (3) | JP2005509495A (de) |
KR (1) | KR20050044507A (de) |
CN (1) | CN1289155C (de) |
AT (1) | ATE526047T1 (de) |
AU (1) | AU2002340463A1 (de) |
BR (1) | BR0214217A (de) |
CA (1) | CA2466487C (de) |
HK (3) | HK1077525A1 (de) |
MX (1) | MXPA04004534A (de) |
WO (1) | WO2003043674A1 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759113B2 (en) * | 1999-04-30 | 2010-07-20 | The General Hospital Corporation | Fabrication of tissue lamina using microfabricated two-dimensional molds |
US20020095157A1 (en) | 1999-07-23 | 2002-07-18 | Bowman Steven M. | Graft fixation device combination |
US6576265B1 (en) | 1999-12-22 | 2003-06-10 | Acell, Inc. | Tissue regenerative composition, method of making, and method of use thereof |
US7776021B2 (en) | 2000-04-28 | 2010-08-17 | The Charles Stark Draper Laboratory | Micromachined bilayer unit for filtration of small molecules |
US8071740B2 (en) | 2000-11-17 | 2011-12-06 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
CA2365376C (en) | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
EP2277887A3 (de) | 2001-10-19 | 2011-02-16 | Vascular Biogenics Ltd. | Polynukleotidkonstrukte, pharmazeutische Zusammensetzungen und Verfahren zur gezielten Abwärtsregulation der Angiogenese und Therapie gegen Krebs |
KR20050044507A (ko) * | 2001-11-16 | 2005-05-12 | 칠드런'즈 메디컬 센터 코포레이션 | 장기 기능의 확장 |
US7824701B2 (en) | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
US20040078090A1 (en) | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
ATE439039T1 (de) | 2003-01-16 | 2009-08-15 | Gen Hospital Corp | Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen |
US8197837B2 (en) | 2003-03-07 | 2012-06-12 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
US20040176855A1 (en) * | 2003-03-07 | 2004-09-09 | Acell, Inc. | Decellularized liver for repair of tissue and treatment of organ deficiency |
US20040175366A1 (en) * | 2003-03-07 | 2004-09-09 | Acell, Inc. | Scaffold for cell growth and differentiation |
EP1636351A4 (de) | 2003-05-21 | 2007-04-04 | Gen Hospital Corp | Mikrofabrizierte zusammensetzungen und verfahren zur konstruktion von geweben mit mehreren zellarten |
AU2004253508A1 (en) | 2003-06-25 | 2005-01-13 | Acell, Inc. | Conditioned matrix compositions for tissue restoration |
US8226715B2 (en) | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
US10583220B2 (en) | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
US7316822B2 (en) | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
US7901461B2 (en) * | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
US11395865B2 (en) | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
US8137686B2 (en) | 2004-04-20 | 2012-03-20 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
US8221780B2 (en) | 2004-04-20 | 2012-07-17 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
CN1314460C (zh) * | 2004-07-15 | 2007-05-09 | 浙江大学 | 将水凝胶复合到多孔组织工程支架中的方法 |
US7759120B2 (en) | 2005-03-02 | 2010-07-20 | Kps Bay Medical, Inc. | Seeding implantable medical devices with cells |
US20060199265A1 (en) * | 2005-03-02 | 2006-09-07 | Wolf Michael F | Seeding implantable medical devices with cells |
JP4991531B2 (ja) | 2005-05-30 | 2012-08-01 | 株式会社オーガンテクノロジーズ | 歯の製造方法、歯の集合体及び組織の製造方法 |
AU2015224503A1 (en) * | 2005-08-26 | 2015-10-01 | Regents Of The University Of Minnesota | Decellularization and recellularization of organs and tissues |
CA2618731C (en) * | 2005-08-26 | 2021-12-28 | Regents Of The University Of Minnesota | Decellularization and recellularization of organs and tissues |
AU2008245900B2 (en) * | 2007-04-24 | 2013-07-25 | Advanced Technologies And Regenerative Medicine, Llc | Engineered renal tissue |
KR20100035637A (ko) * | 2007-06-08 | 2010-04-05 | 웨이크 포리스트 유니버시티 헬스 사이언시즈 | 신부전 치료를 위한 선택적 세포 치료법 |
US9580688B2 (en) | 2007-06-08 | 2017-02-28 | Wake Forest University Health Sciences | Kidney structures and methods of forming the same |
US10590391B2 (en) | 2007-06-08 | 2020-03-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
US8425591B1 (en) | 2007-06-11 | 2013-04-23 | Abbott Cardiovascular Systems Inc. | Methods of forming polymer-bioceramic composite medical devices with bioceramic particles |
EP2358375B1 (de) * | 2008-11-12 | 2013-07-24 | Tengion, Inc. | Isolierte nierenzellen und verwendungen dafür |
IL196820A0 (en) * | 2009-02-01 | 2009-11-18 | Yissum Res Dev Co | Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells |
US8298586B2 (en) | 2009-07-22 | 2012-10-30 | Acell Inc | Variable density tissue graft composition |
US8652500B2 (en) | 2009-07-22 | 2014-02-18 | Acell, Inc. | Particulate tissue graft with components of differing density and methods of making and using the same |
JP2011135836A (ja) * | 2009-12-28 | 2011-07-14 | Cell Remover:Kk | 細胞培養基材 |
ES2906750T3 (es) | 2010-05-12 | 2022-04-20 | Prokidney | Células renales bioactivas |
JP5931878B2 (ja) * | 2010-09-01 | 2016-06-08 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 移植可能性の改良のための組織または器官の再細胞化法 |
CA3065694A1 (en) | 2010-11-10 | 2012-05-18 | Inregen | Methods of forming injectable formulations for providing regenerative effects to an organ such as a kidney |
JP6158175B2 (ja) * | 2011-05-27 | 2017-07-05 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | バイオ人工近位尿細管システム及びその使用方法 |
CN103987392A (zh) * | 2011-09-02 | 2014-08-13 | Adeka株式会社 | 脱细胞化组织制品的制备方法、及具备脱细胞化组织制品的移植片 |
US9877822B2 (en) | 2012-04-24 | 2018-01-30 | Biostage, Inc. | Engineered tissue scaffolds and supports therefor |
US9290738B2 (en) | 2012-06-13 | 2016-03-22 | Miromatrix Medical Inc. | Methods of decellularizing bone |
EP2943231A4 (de) | 2013-01-09 | 2016-12-07 | Harvard Apparatus Regenerative Tech Inc | Synthetische gerüste |
CN103120808B (zh) * | 2013-01-16 | 2015-03-18 | 西北工业大学 | 一种三维软体支架的制备方法 |
CN103120806B (zh) * | 2013-01-16 | 2015-04-15 | 西北工业大学 | 一种基于pva水凝胶软骨支架的制备方法 |
CN103120807B (zh) * | 2013-01-16 | 2015-03-18 | 西北工业大学 | 一种冰致微结构软体组织的制备方法 |
KR102278652B1 (ko) | 2013-03-15 | 2021-07-19 | 미로매트릭스 메디칼 인크. | 섬 세포 재세포화를 위한 관류 탈세포화된 간의 용도 |
US11123372B2 (en) | 2016-07-29 | 2021-09-21 | Prokidney | Bioactive renal cells for the treatment of chronic kidney disease |
US11278643B2 (en) | 2016-09-06 | 2022-03-22 | Mayo Foundation For Medical Education And Research | Use of resected liver serum for whole liver-engineering |
US11944719B2 (en) * | 2016-12-16 | 2024-04-02 | Iviva Medical, Inc. | Thin film interposition of basement membrane scaffolds |
KR20200065892A (ko) * | 2018-11-30 | 2020-06-09 | 오가노이드사이언스 주식회사 | 오가노이드의 생체 이식용 조성물 |
CN110279897A (zh) * | 2019-07-15 | 2019-09-27 | 湖南大学 | 一种新型人工微器官 |
CA3164358A1 (en) * | 2020-01-28 | 2021-08-05 | Kidneycure Ltd | Process for kidney cell manufacture and treatment |
US11998662B1 (en) | 2021-06-09 | 2024-06-04 | Reprise Biomedical, Inc. | Biologic matrix for a wound site and related methods |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3463158A (en) * | 1963-10-31 | 1969-08-26 | American Cyanamid Co | Polyglycolic acid prosthetic devices |
US4182339A (en) * | 1978-05-17 | 1980-01-08 | Hardy Thomas G Jr | Anastomotic device and method |
US4297173A (en) * | 1980-05-22 | 1981-10-27 | Ajinomoto Company, Incorporated | Method for determining ammonia and sensor therefor |
US4458678A (en) * | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
US4520821A (en) * | 1982-04-30 | 1985-06-04 | The Regents Of The University Of California | Growing of long-term biological tissue correction structures in vivo |
US4483987A (en) * | 1983-06-20 | 1984-11-20 | G. D. Searle & Co. | 8-Substituted 7-phenyl-1,2,4-triazolo[2,3-c]pyrimidines-5-amines and amides |
US4594407A (en) * | 1983-09-20 | 1986-06-10 | Allied Corporation | Prosthetic devices derived from krebs-cycle dicarboxylic acids and diols |
IL78950A (en) * | 1985-06-06 | 1991-12-15 | Univ Jefferson | Coating for prosthetic devices |
US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US5160490A (en) * | 1986-04-18 | 1992-11-03 | Marrow-Tech Incorporated | Three-dimensional cell and tissue culture apparatus |
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US4769037A (en) * | 1986-10-28 | 1988-09-06 | Midcalf Robert J | Artificial replacement kidney implant and method of dialyzing blood |
CA1340581C (en) * | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
US5804178A (en) * | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
US5567612A (en) * | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
GB8722854D0 (en) * | 1987-09-29 | 1987-11-04 | Hardy S M | Implantable artificial kidney |
US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US5085629A (en) * | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
US5429936A (en) * | 1989-04-21 | 1995-07-04 | The Regents Of The University Of California | Antibody-mediated juxtaposition of reactive moieties |
US4996154A (en) * | 1989-05-04 | 1991-02-26 | Millipore Corporation | Method for growing cellular tissue |
US5261898A (en) * | 1990-11-13 | 1993-11-16 | Polin Stanton G | Temporary colostomy apparatus |
US5192312A (en) * | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
WO1993007913A1 (en) * | 1991-10-24 | 1993-04-29 | Children's Medical Center Corporation | Neomorphogenesis of urological structures in vivo from cell culture |
NZ245015A (en) * | 1991-11-05 | 1995-12-21 | Transkaryotic Therapies Inc | Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production |
US5376376A (en) * | 1992-01-13 | 1994-12-27 | Li; Shu-Tung | Resorbable vascular wound dressings |
CA2059392C (fr) * | 1992-01-15 | 1998-08-18 | Denis Cote | Pompe a pression et a recirculation |
US5429938A (en) | 1992-03-02 | 1995-07-04 | University Of Michigan | Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
US6410320B1 (en) * | 1992-03-02 | 2002-06-25 | The University Of Michigan | Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
US5549674A (en) * | 1992-03-02 | 1996-08-27 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
US6060270A (en) * | 1992-03-02 | 2000-05-09 | The University Of Michigan | Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
US5441870A (en) * | 1992-04-15 | 1995-08-15 | Athena Neurosciences, Inc. | Methods for monitoring cellular processing of β-amyloid precursor protein |
EP0637229B1 (de) * | 1992-04-24 | 2002-11-20 | Osteotech, Inc., | Vorrichtung zum vermeiden von gewebeadhäsionen |
US5224953A (en) * | 1992-05-01 | 1993-07-06 | The Beth Israel Hospital Association | Method for treatment of obstructive portions of urinary passageways |
US5800537A (en) * | 1992-08-07 | 1998-09-01 | Tissue Engineering, Inc. | Method and construct for producing graft tissue from an extracellular matrix |
US5957972A (en) * | 1992-09-29 | 1999-09-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Implants possessing a surface of endothelial cells genetically-modified to inhibit intimal thickening |
US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
US5433996A (en) * | 1993-02-18 | 1995-07-18 | W. L. Gore & Associates, Inc. | Laminated patch tissue repair sheet material |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5451613A (en) | 1993-09-17 | 1995-09-19 | Nalco Chemical Company | Superabsorbent polymer having improved absorption rate and absorption under pressure |
WO1995024873A1 (en) * | 1994-03-14 | 1995-09-21 | Cryolife, Inc. | Treated tissue for implantation and preparation methods |
US5916265A (en) * | 1994-03-30 | 1999-06-29 | Hu; Jie | Method of producing a biological extracellular matrix for use as a cell seeding scaffold and implant |
US5626861A (en) * | 1994-04-01 | 1997-05-06 | Massachusetts Institute Of Technology | Polymeric-hydroxyapatite bone composite |
US5947893A (en) * | 1994-04-27 | 1999-09-07 | Board Of Regents, The University Of Texas System | Method of making a porous prothesis with biodegradable coatings |
US5545131A (en) * | 1994-04-28 | 1996-08-13 | White Eagle International Technologies, Lp | Artificial kidney |
NZ293419A (en) * | 1994-09-12 | 1998-11-25 | Advanced Tissue Sciences Inc | Stromal cell-coated heart valves, production thereof |
US5429674A (en) * | 1994-09-12 | 1995-07-04 | Ppg Industries, Inc. | N-acyl aminomethylene phosphonates and their use in waterborne coating compositions |
US5654273A (en) | 1994-09-22 | 1997-08-05 | Children's Medical Center Corporation | Synducin mediated modulation of tissue repair |
US5695996A (en) * | 1994-09-23 | 1997-12-09 | The United States Of America As Represented By The Department Of Health And Human Services | Artificial organ culture system |
US5716404A (en) * | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
AU692094B2 (en) * | 1995-04-07 | 1998-05-28 | Methodist Health Group, Inc. | Tissue graft and method for urinary bladder reconstruction |
US5855610A (en) * | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
US6171344B1 (en) * | 1996-08-16 | 2001-01-09 | Children's Medical Center Corporation | Bladder submucosa seeded with cells for tissue reconstruction |
ATE260076T1 (de) * | 1996-09-05 | 2004-03-15 | Childrens Medical Center | Nierenprothese |
US6673339B1 (en) * | 1996-09-05 | 2004-01-06 | Children's Medical Center Corporation | Prosthetic kidney and its use for treating kidney disease |
US5952226A (en) * | 1996-11-05 | 1999-09-14 | Modex Therapeutiques | Hypoxia responsive EPO producing cells |
US5967972A (en) * | 1997-03-28 | 1999-10-19 | Kapp Surgical Instrument, Inc. | Minimally invasive surgical retractor and method of operation |
DE59803925D1 (de) * | 1997-06-27 | 2002-05-29 | Augustinus Bader | Bioartifizielles transplantat und verfahren zu seiner herstellung |
DE69817863T2 (de) * | 1997-10-31 | 2004-07-15 | Children's Medical Center Corp., Boston | Blasenrekonstruktion |
US6777205B1 (en) * | 1998-11-06 | 2004-08-17 | Sterrenbeld Biotechnologie North America, Inc. | Host cells expressing recombinant human erythropoietin |
DE19919625C2 (de) * | 1999-04-29 | 2002-10-31 | Symetis Ag Zuerich | In-vitro-Verfahren zum Herstellen einer homologen Herzklappe und durch dieses Verfahren herstellbare Klappe |
WO2000066036A2 (en) * | 1999-04-30 | 2000-11-09 | Massachusetts General Hospital | Fabrication of vascularized tissue using microfabricated two-dimensional molds |
GB9910377D0 (en) * | 1999-05-05 | 1999-06-30 | Univ Westminster | Tissue engineering |
WO2000067776A1 (en) * | 1999-05-11 | 2000-11-16 | Ortho-Mcneil Pharmaceuticals, Inc. | Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
US20040167634A1 (en) * | 1999-05-26 | 2004-08-26 | Anthony Atala | Prosthetic kidney and its use for treating kidney disease |
JP3603179B2 (ja) * | 1999-09-09 | 2004-12-22 | グンゼ株式会社 | 心血管系組織培養用基材および組織再生法 |
US20030180289A1 (en) * | 1999-09-23 | 2003-09-25 | Foster Keith Alan | Inhibition of secretion from non-neuronal cells |
US6503330B1 (en) * | 1999-12-22 | 2003-01-07 | Genus, Inc. | Apparatus and method to achieve continuous interface and ultrathin film during atomic layer deposition |
US6368859B1 (en) * | 1999-12-29 | 2002-04-09 | Children's Medical Center Corporation | Methods and compositions for producing a fascial sling |
US6376244B1 (en) * | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
US6428802B1 (en) * | 1999-12-29 | 2002-08-06 | Children's Medical Center Corp. | Preparing artificial organs by forming polylayers of different cell populations on a substrate |
US6479064B1 (en) * | 1999-12-29 | 2002-11-12 | Children's Medical Center Corporation | Culturing different cell populations on a decellularized natural biostructure for organ reconstruction |
US7326570B2 (en) * | 2000-06-16 | 2008-02-05 | The Regents Of The University Of California | Induction of tubular morphogenesis using pleiotrophin |
US7326564B2 (en) * | 2001-02-20 | 2008-02-05 | St. Jude Medical, Inc. | Flow system for medical device evaluation and production |
US6656488B2 (en) * | 2001-04-11 | 2003-12-02 | Ethicon Endo-Surgery, Inc. | Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering |
US6784154B2 (en) * | 2001-11-01 | 2004-08-31 | University Of Utah Research Foundation | Method of use of erythropoietin to treat ischemic acute renal failure |
KR20050044507A (ko) * | 2001-11-16 | 2005-05-12 | 칠드런'즈 메디컬 센터 코포레이션 | 장기 기능의 확장 |
US20030180268A1 (en) * | 2002-02-05 | 2003-09-25 | Anthony Atala | Tissue engineered construct for supplementing or replacing a damaged organ |
US8940292B2 (en) * | 2003-01-28 | 2015-01-27 | Wake Forest University Health Sciences | Enhancement of angiogenesis to grafts using cells engineered to produce growth factors |
US8084424B2 (en) * | 2003-04-09 | 2011-12-27 | University Of Utah Research Foundation | Compositions and methods related to erythropoietin |
US20050002919A1 (en) * | 2003-06-09 | 2005-01-06 | The Brigham And Women's Hospital, Inc. | Cadherin directed molecular and cellular localization |
US20050136042A1 (en) * | 2003-08-12 | 2005-06-23 | Betz Oliver B. | Methods and compositions for tissue repair |
WO2007035843A2 (en) * | 2005-09-21 | 2007-03-29 | Dask Technologies, Llc | Methods and compositions for organ and tissue functionality |
US10590391B2 (en) * | 2007-06-08 | 2020-03-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
KR20100035637A (ko) * | 2007-06-08 | 2010-04-05 | 웨이크 포리스트 유니버시티 헬스 사이언시즈 | 신부전 치료를 위한 선택적 세포 치료법 |
US9580688B2 (en) * | 2007-06-08 | 2017-02-28 | Wake Forest University Health Sciences | Kidney structures and methods of forming the same |
-
2002
- 2002-11-12 KR KR1020047007513A patent/KR20050044507A/ko not_active Application Discontinuation
- 2002-11-12 CA CA2466487A patent/CA2466487C/en not_active Expired - Fee Related
- 2002-11-12 AU AU2002340463A patent/AU2002340463A1/en not_active Abandoned
- 2002-11-12 JP JP2003545352A patent/JP2005509495A/ja not_active Withdrawn
- 2002-11-12 AT AT06022636T patent/ATE526047T1/de not_active IP Right Cessation
- 2002-11-12 EP EP10010950.3A patent/EP2292278B1/de not_active Expired - Lifetime
- 2002-11-12 WO PCT/US2002/036202 patent/WO2003043674A1/en not_active Application Discontinuation
- 2002-11-12 EP EP02778827A patent/EP1446171A1/de not_active Withdrawn
- 2002-11-12 US US10/292,166 patent/US20030124099A1/en not_active Abandoned
- 2002-11-12 CN CNB028272285A patent/CN1289155C/zh not_active Expired - Fee Related
- 2002-11-12 MX MXPA04004534A patent/MXPA04004534A/es active IP Right Grant
- 2002-11-12 BR BR0214217-1A patent/BR0214217A/pt not_active Application Discontinuation
- 2002-11-12 EP EP06022636A patent/EP1752168B1/de not_active Expired - Lifetime
-
2005
- 2005-10-21 HK HK05109415A patent/HK1077525A1/xx not_active IP Right Cessation
-
2006
- 2006-06-30 US US11/479,252 patent/US20070116679A1/en not_active Abandoned
-
2007
- 2007-06-22 HK HK07106694.9A patent/HK1099528A1/xx not_active IP Right Cessation
- 2007-06-22 HK HK11108560.0A patent/HK1154358A1/xx not_active IP Right Cessation
-
2009
- 2009-12-17 JP JP2009286549A patent/JP2010063910A/ja not_active Withdrawn
-
2010
- 2010-09-08 US US12/877,282 patent/US20110059152A1/en not_active Abandoned
-
2013
- 2013-09-17 JP JP2013191823A patent/JP2013248536A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2013248536A (ja) | 2013-12-12 |
MXPA04004534A (es) | 2004-08-11 |
US20030124099A1 (en) | 2003-07-03 |
EP1752168A2 (de) | 2007-02-14 |
JP2005509495A (ja) | 2005-04-14 |
EP2292278B1 (de) | 2013-04-24 |
HK1154358A1 (en) | 2012-04-20 |
US20110059152A1 (en) | 2011-03-10 |
CN1289155C (zh) | 2006-12-13 |
EP2292278A3 (de) | 2011-05-18 |
CA2466487A1 (en) | 2003-05-30 |
US20070116679A1 (en) | 2007-05-24 |
EP1446171A1 (de) | 2004-08-18 |
BR0214217A (pt) | 2004-09-21 |
HK1099528A1 (en) | 2007-08-17 |
HK1077525A1 (en) | 2006-02-17 |
EP1752168A3 (de) | 2008-06-04 |
EP2292278A2 (de) | 2011-03-09 |
KR20050044507A (ko) | 2005-05-12 |
CN1615162A (zh) | 2005-05-11 |
AU2002340463A1 (en) | 2003-06-10 |
CA2466487C (en) | 2011-04-05 |
JP2010063910A (ja) | 2010-03-25 |
EP1752168B1 (de) | 2011-09-28 |
WO2003043674A1 (en) | 2003-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE526047T1 (de) | Verbesserung der funktion von organen | |
ES2351875T3 (es) | Utilización de inhibidores de las lisil oxidasas para el cultivo celular y la ingeniería tisular. | |
Wiedmann-Al-Ahmad et al. | How to optimize seeding and culturing of human osteoblast-like cells on various biomaterials | |
RU2006145431A (ru) | Композиция для репарации хрящевой и костной ткани | |
ATE332964T1 (de) | Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe | |
JPS59192364A (ja) | 軟骨および骨の修復方法 | |
TR200100482T2 (tr) | Kondrosit hücre transplantasyonu için metodlar; enstrümanlar ve maddeler | |
ATE295875T1 (de) | Verfahren zur in vitro herstellung von knochen | |
HK1064021A1 (en) | Instruments for autologous transplantation | |
Turhani et al. | In vitro growth and differentiation of osteoblast-like cells on hydroxyapatite ceramic granule calcified from red algae | |
Gebhardt et al. | Cell survival within pulp and periodontal constructs | |
Cai et al. | Lapine and canine bone marrow stromal cells contain smooth muscle actin and contract a collagen-glycosaminoglycan matrix | |
Yang et al. | A novel possible strategy based on self‐assembly approach to achieve complete periodontal regeneration | |
WO2004092359A1 (ja) | 移植用軟骨細胞の製法 | |
Turhani et al. | Three‐dimensional composites manufactured with human mesenchymal cambial layer precursor cells as an alternative for sinus floor augmentation: an in vitro study | |
CN1241652C (zh) | 人工骨骼材料 | |
Iida et al. | Osteogenic potential of cultured bone/ceramic construct: comparison with marrow mesenchymal cell/ceramic composite | |
JP3897717B2 (ja) | 細胞移植治療材料およびその製造方法 | |
US20050100533A1 (en) | Structures useful for bone engineering and methods | |
Gurpinar et al. | Effect of enamel matrix derivative on mouse fibroblasts and marrow stromal osteoblasts | |
Keyhan et al. | Tissue engineering applications in maxillofacial surgery | |
RU2006116152A (ru) | Способ восстановления кости альвеолярного гребня челюсти и тканей пародонта с редуцированным регенераторным потенциалом | |
WO2001082773A3 (en) | Structures useful for bone engineering and methods | |
Shikarkhane et al. | Ligaplants: A Natural Implant: Myth or Hope?: A Literature Review | |
Kamdenlek et al. | Assessment of Alveolar Bone Cell Sheet Compatibility on Protein-Modified Alginate Membranes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |